Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LPNT > SEC Filings for LPNT > Form 8-K on 9-Dec-2013All Recent SEC Filings

Show all filings for LIFEPOINT HOSPITALS, INC.

Form 8-K for LIFEPOINT HOSPITALS, INC.


9-Dec-2013

Entry into a Material Definitive Agreement, Creation of a Direct Financ


Item 1.01 Entry into a Material Definitive Agreement

1. Indenture and Senior Notes due 2021

On December 6, 2013 LifePoint Hospitals, Inc. (NASDAQ: LPNT) (the "Company") issued $700,000,000 aggregate principal amount of 5.5% senior notes due 2021 (the "Notes"), which mature on December 1, 2021, pursuant to an indenture, dated December 6, 2013, between the Company, the Guarantors (as defined therein) and Bank of New York Mellon Trust Company, N.A., as trustee (the "Indenture"). The Notes are guaranteed by certain of the Company's existing and future domestic subsidiaries and were sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to non-U.S. persons in accordance with Regulation S under the Securities Act.

The Company will pay interest on the Notes at a rate of 5.5% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, commencing June 1, 2014.

The Company may redeem the Notes, in whole or part, at any time prior to December 1, 2016 at a price equal to 100% of the principal amount of the Notes redeemed plus an applicable "make whole" premium, plus accrued and unpaid interest, if any, to the date of redemption. The Company may redeem the Notes, in whole or in part, at any time on or after December 1, 2016, at specified redemption prices plus accrued and unpaid interest, if any, to the date of redemption. At any time before December 1, 2016, the Company may redeem up to 35% of the aggregate principal amount of the Notes issued under the indenture with the net cash proceeds of one or more qualified equity offerings at a redemption price equal to 105.500% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest; provided that: at least 65% of the aggregate principal amount of the Notes remains outstanding immediately after the occurrence of such redemption; and such redemption occurs within 180 days of the date of the closing of any such qualified equity offering.

In the event of a Change of Control (as defined in the Indenture) the Company will be required to offer to repurchase all of the Notes at a repurchase price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the date of repurchase.

The Indenture contains covenants that limit the Company's ability and the ability of Company's restricted subsidiaries to, among other things: incur additional indebtedness, pay dividends or repurchase capital stock, make certain investments, create liens, enter into certain types of transactions with our affiliates and sell assets or consolidate or merge with or into other companies. These covenants are subject to a number of important limitations and exceptions. The Indenture also provides for events of default, which, if any of them occurs, would permit or require the principal, premium, if any, interest and any other monetary obligations on all the then outstanding Notes to be due and payable immediately.

The foregoing summary is qualified in its entirety by reference to the Indenture, a copy of which is filed as Exhibit 4.1 to this Form 8-K.

2. Registration Rights Agreement

In connection with the issuance of the Notes, the Company and the Guarantors entered into a registration rights agreement , dated as of December 6, 2013 (the "Registration Rights Agreement") with Barclays Capital Inc. as representative of the several initial purchasers (the "Initial Purchasers") in connection with the Notes, pursuant to the Indenture (as described above).

The Company has agreed to use commercially reasonable efforts to register with the SEC exchange notes having substantially identical terms as the Notes and will use commercially reasonable efforts to have an exchange offer registration statement declared effective, and cause such exchange offer to be completed no later than 360 calendar days after the original issue date of the Notes. Under certain circumstances, the Company may be required to file a shelf registration statement with respect to the Notes.


If the Company fails to meet the conditions set forth in the Registration Rights Agreement, it has agreed to pay additional interest to the holders of the affected Notes under certain circumstances. Any references to "interest" herein shall include any additional interest due and payable pursuant to the registration rights agreement.

The foregoing summary is qualified in its entirety by reference to the Registration Rights Agreement, a copy of which is filed as Exhibit 4.2 to this Form 8-K.



Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet Arrangement of a Registrant

The information set forth under Item 1.01 above is incorporated by reference into this Item 2.03.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.                                 Description
    4.1       Indenture, dated as of December 6, 2013, by and among LifePoint
              Hospitals, Inc., the Guarantors (as defined therein) and Bank of New
              York Mellon Trust Company, N.A. as trustee (including the Form of 5.5%
              Senior Note due 2021).

    4.2       Registration Rights Agreement, dated as of December 6, 2013, by and
              among LifePoint Hospitals, Inc., the Guarantors (as defined therein)
              and Barclays Capital Inc. as representative of the several initial
              purchasers.


  Add LPNT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LPNT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.